Azelaic Acid 15% Gel: In the Treatment of Papulopustular Rosacea
Authors: Frampton J.E.1; Wagstaff A.J.1
Source: American Journal of Clinical Dermatology, Volume 5, Number 1, 2004 , pp. 57-64(8)
Publisher: Adis International
Key:
- Free Content
- New Content
- Subscribed Content
- Free Trial Content
Abstract:
Azelaic acid is a naturally occurring, straight-chain dicarboxylic acid which is effective in the treatment of rosacea, presumably on account of its anti-inflammatory properties.
In randomized, double-blind, multicenter studies involving patients with moderate papulopustular facial rosacea, twice-daily topical application of azelaic acid 15% gel to the face was significantly more effective than twice-daily administration of either its vehicle (two studies) or metronidazole 0.75% gel (one study) in reducing inflammatory lesion counts and erythema severity. However, neither active treatment had a clinically discernable effect on telangiectasia.
In all three studies, azelaic acid 15% gel recipients experienced continuous decreases in lesion counts and erythema throughout the 12- to 15-week treatment periods. However, the effects of metronidazole 0.75% gel plateauxed after 8 weeks.
In other efficacy assessments in these studies, azelaic acid 15% gel was superior to its vehicle and metronidazole 0.75% gel in both the investigators' global assessment of rosacea and the investigators' end-of-study evaluation of overall improvement, and superior to its vehicle in the patients' end-of-study evaluation of overall improvement.
The most frequent treatment-related cutaneous adverse events during administration of azelaic acid 15% gel include burning/stinging/tingling and pruritus (itching); however, these events are predominantly transient in nature and mild-to-moderate in intensity.
Keywords: Adis Drug Profiles; Azelaic acid, therapeutic use; Antiacnes, therapeutic use; Rosacea, treatment
Document Type: Research article
Affiliations: 1: Adis International Inc., Yardley, Pennsylvania, USA
Key:
- Free Content
- New Content
- Subscribed Content
- Free Trial Content

Click here for Page Help